Stevanato Group S.p.A. (STVN) Stock Price & Analysis
Stevanato Group S.p.A. (STVN) closed at USD 19.5 on Thursday, October 22, 2026, up 3.61% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 18.82; the Oct 22, 2026 session ranged USD 18.83–19.88 on volume of 961,517 shares. Market capitalization is $5.33B, with a 52-week range of USD 12.89–27.99 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:27 UTC.
Also available as compact Markdown for AI agents: nexqual.com/STVN.md
Key facts (STVN)
- 1 of 80 tracked superinvestors hold STVN (13F, Q2 2026): 0 new, 1 added, 0 reduced, 0 unchanged.
- Total return with dividends: 1Y -29.1% vs S&P 500 +14.9%; 5Y -20.4% vs S&P 500 +80.3%.
- Next earnings: 2026-11-03, EPS estimate USD 0.18, revenue estimate $321M.
Superinvestors (SEC 13F-HR, Q2 2026) (STVN)
1 of 80 tracked investors hold STVN. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| First Eagle Investment | First Eagle Investment Management | 0.02% | $11.0M | Added +288.1% |
Analysts (STVN)
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-09 | UBS | Target lowered | Neutral | $28 → $23 |
Total return (dividends reinvested) (STVN)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | -29.1% | -20.4% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -29.2% | -4.5% |
| Volatility (annualized) | 45.4% | 47.0% |
| Max drawdown | -51.4% (Oct 2025→Mar 2026) | -59.4% (Aug 2023→Mar 2026) |
STVN analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.18 | $0.18 | -2.8% | $320.7M | 10 |
| Next quarter (ends Dec 2026) | $0.24 | $0.24 | -1.7% | $371.2M | 9 |
| Current fiscal year (ends Dec 2026) | $0.70 | $0.70 | -0.6% | $1.27B | 13 |
| Next fiscal year (ends Dec 2027) | $0.83 | $0.83 | -0.4% | $1.38B | 13 |
Key Statistics (as of October 23, 2026 at 09:27 UTC)
| Price | USD 19.5 |
|---|---|
| Change | ▲ 3.61% (up) |
| Previous Close | USD 18.82 |
| Open | USD 18.88 |
| Day Range | USD 18.83 – 19.88 |
| 52-Week Range | USD 12.89 – 27.99 |
| Volume | 961,517 shares |
| Market Cap | $5.33B |
| Exchange | NYQ |
Technical Analysis (STVN)
Nexqual's technical model rates STVN "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of October 23, 2026 at 09:27 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 46.73 (neutral) |
| vs SMA50 | Below (USD 20.8) |
| MACD | -0.51 (negative) |
Earnings (STVN)
| Next Earnings Date | 2026-11-03 |
|---|---|
| EPS Estimate | USD 0.18 |
| Revenue Estimate | $320.67M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.16 vs est 0.15 ▲ beat |
| 2026-03-31 | USD 0.13 vs est 0.12 ▲ beat |
| 2025-12-31 | USD 0.21 vs est 0.2 ▲ beat |
| 2025-09-30 | USD 0.16 vs est 0.15 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Financials & Fundamentals (STVN)
| Total Revenue | $1.23B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +7.80% |
| Gross Margin | +29.40% |
| Operating Margin | +17.22% |
| Profit Margin | +10.99% |
| ROE | +9.13% |
| Debt / Equity | 0.29 |
| Current Ratio | 1.61 |
| Total Cash | $79.14M |
| Total Debt | $445.30M |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Financial Health Score (STVN)
Nexqual rates Stevanato Group S.p.A.'s overall financial health "Solid" across five dimensions, as of October 23, 2026 at 09:27 UTC.
| Growth | Solid — Revenue +7% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 29%, operating 17% (last 12 months) |
| Balance Sheet | Strong — EUR 79M cash vs EUR 445M debt |
| Cash Flow | Solid — Operating cash flow EUR 249M (TTM) |
| Efficiency | Mixed — ROE 9%, ROA 5.4% |
Ownership (STVN)
| Insider Ownership | +1.78% |
|---|---|
| Institutional Ownership | +100.37% |
| Shares Outstanding | 49.83M |
| Float | 49.04M |
| Short % of Float | +2.22% |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Leadership (STVN)
Stevanato Group S.p.A. is led by Franco Stevanato, CEO & Executive Chairman, per Nexqual as of October 23, 2026 at 09:27 UTC.
| CEO & Executive Chairman | Franco Stevanato |
|---|---|
| Chief Financial Officer | Marco Dal Lago |
| President of DDS & IVD Business Unit | Michele Monico |
| President of Engineering Business Unit | Raffaele Pace |
Major Backers & Investors (STVN)
Notable institutional backers of Stevanato Group S.p.A. include Conestoga Capital Advisors, LLC, Neuberger Berman Group, LLC, Conestoga Funds-Conestoga Small Cap Fund, according to Nexqual as of October 23, 2026 at 09:27 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Conestoga Capital Advisors, LLC | 2.31% |
| Neuberger Berman Group, LLC | 1.86% |
| Conestoga Funds-Conestoga Small Cap Fund | 1.35% |
| Times Square Capital Management, LLC | 1.15% |
| Van Berkom & Associates Inc. | 0.98% |
| Artisan Partners Limited Partnership | 0.86% |
| BAMCO Inc. | 0.82% |
| BARON INVESTMENT Fd.S TRT -BARON DISCOVERY Fd. | 0.56% |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MMED | MiniMed Group, Inc. | USD 18.29 | ▲ 2.75% |
| MMSI | Merit Medical Systems, Inc. | USD 93.94 | ▲ 2.78% |
| TFX | Teleflex Incorporated | USD 136.58 | ▲ 4.74% |
| BLCO | Bausch + Lomb Corporation | USD 17.43 | ▲ 1.46% |
| ICUI | ICU Medical, Inc. | USD 168.33 | ▲ 4.66% |
| NVST | Envista Holdings Corporation | USD 23.97 | ▲ 3.36% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:27 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt